Amyloidosis Meeting/Tumor Board- MOC Eligible 2020

Add to Calendar Amyloidosis Meeting/Tumor Board- MOC Eligible 2020 1/1/2020 5:00:00 PM 1/1/2020 6:00:00 PM America/Chicago For More Details: https://vumc.cloud-cme.com/course/courseoverview?EID=25079 Description: Cases of patients who have been diagnosed with malignant hematologic tumors are reviewed in this tumor board to ensure that a care plan has been developed appropriate to the patient's wishes and condition as well as the complexity of the tumor.This educational activity received no commercial support.January 1, 2020 - November 30, 2020 only:Successful completion of this CME activity, which includes parti... 898K PRB false MM/DD/YYYY


Occurs monthly on the 2nd Wednesday starting on 1/1/2020 at 5:00 PM
Wednesday, January 1, 2020, 5:00 PM - 6:00 PM, 898K PRB


Specialties - Medicine, Neurology, Pathology, Microbiology and Immunology, Radiation Oncology, Radiology and Radiological Sciences, Surgery


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)


Cases of patients who have been diagnosed with malignant hematologic tumors are reviewed in this tumor board to ensure that a care plan has been developed appropriate to the patient's wishes and condition as well as the complexity of the tumor.

This educational activity received no commercial support. 

January 1, 2020 - November 30, 2020 only:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. 

Objectives
After participating in this CME activity, participants should be able to describe and discuss:

  1. Current clinical features, molecular biology and emerging therapies in managing patients diagnosed with amyloidosis.
  2. Recent advances in the basic sciences relevant to amyloidosis
  3. Recent advances in laboratory evaluation that have facilitated improved management of patients' amyloidosis


Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

January 1, 2020 - November 30, 2020 only:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. 

Vanderbilt University Medical Center designates this live activity for a maximum 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.